Keyphrases
Cardiovascular Risk
100%
Obesity
100%
Receptor Agonist
100%
A1 Receptor
100%
Weight Loss
100%
Glucagon-like
100%
Cardiovascular Outcomes
100%
Healthcare Professionals
50%
Obesity Treatment
50%
Type 2 Diabetes Mellitus (T2DM)
50%
United States
25%
Cardiovascular Mortality
25%
Lifestyle Modification
25%
Public Health Risk
25%
Pharmacological Therapy
25%
Cardiovascular Prevention
25%
Disease Onset
25%
Chronic Disease
25%
Clinical Practice
25%
Obesity Management
25%
Risk Reduction
25%
Treatment Paradigms
25%
Pharmacologic Interventions
25%
Overweight or Obesity
25%
Weight Management
25%
Potential Reduction
25%
Bariatric Surgery
25%
Management Guidelines
25%
Agonist Drugs
25%
Diabetes Status
25%
Patients with Obesity
25%
Obesity Reduction
25%
Obesity-related Complications
25%
Medicine and Dentistry
Cardiovascular System
100%
Cardiovascular Disease
100%
Obesity
100%
Glucagon-Like Peptide-1 Agonist
100%
Health Care
33%
Maturity Onset Diabetes of the Young
33%
Patient with Obesity
33%
Disease
16%
Drug Therapy
16%
Public Health
16%
Lifestyle Modification
16%
Chronic Disease
16%
Primary Prevention
16%
Weight Management
16%
Bariatric Surgery
16%
Patient with Overweight
16%
Nursing and Health Professions
Cardiovascular Disease
100%
Obesity
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Health Care Personnel
33%
Non Insulin Dependent Diabetes Mellitus
33%
Patient with Obesity
33%
Disease
16%
Lifestyle Modification
16%
Drug Therapy
16%
Practice Guideline
16%
Chronic Disease
16%
Clinical Practice
16%
Primary Prevention
16%
Weight Management
16%
Bariatric Surgery
16%
Obesity Management
16%
Patient with Overweight
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
Obesity
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Non Insulin Dependent Diabetes Mellitus
33%
Disease
16%
Chronic Disease
16%